RankAlpha logo
Back to Rankings

CUE

Cue BiopharmaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CUE vs peer average
47/100
CUE vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · C 1 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BRNS is the first available peer comparator.

Barinthus Biotherapeutics is a looser but still useful clinical-stage immunotherapy peer for comparing milestone dependence and funding resilience, though its disease focus is less directly aligned.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBRNSBarinthus Biotherapeutics
CUE
Cue Biopharma
BRNS
Barinthus Biotherapeutics
Grade
D
F
Momentum
99
9
Value
41
58
Sentiment
0
-
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs BRNS

CUE / BRNS
Grade Position
In line
CUE vs. peer average (D vs. D)
47/100
Momentum
99
CUE
Value
41
BRNS
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CUE
1
BRNS
BRNS
F
20/100
+1
2
MRKR
MRKR
B
80/100
-2
3
SNTI
SNTI
F
20/100
+1
4
ATLN
Atlantic International Corp Common
F
20/100
+1
5
ALPS
ALPS Group Inc Common
F
20/100
+1
BRNS is the first peer returned for this comparison set.